ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Grants Funding: New Funds Moved Into R01s, other Extramural Priorities

December 12, 1997

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

In Brief: Lee Helman To Head NCI Pediatric Branch; HHS to Hear From Academic Health Centers

August 22, 1997

In Brief: UCSD Recruits Mitchell From USC; Wade Wins Policy Fellowship; ASCO Honors Burchenal

July 15, 1994

U.S. Breast Cancer Death Rate Declines.

September 28, 2007

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

July 7, 1995